94 related articles for article (PubMed ID: 7825480)
1. Finding colorectal tumours with an immunological faecal occult blood test in symptomatic primary health care patients.
Kemppainen M; Häkkinen I; Räihä I; Pomoell R; Sourander L
Age Ageing; 1994 Sep; 23(5):365-70. PubMed ID: 7825480
[TBL] [Abstract][Full Text] [Related]
2. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
[TBL] [Abstract][Full Text] [Related]
4. Immunological detection of faecal occult blood in colorectal cancer.
Turunen MJ; Liewendahl K; Partanen P; Adlercreutz H
Br J Cancer; 1984 Feb; 49(2):141-8. PubMed ID: 6696817
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
6. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.
Häkkinen I; Paasivuo R; Partanen P
Gut; 1988 Sep; 29(9):1194-7. PubMed ID: 3197992
[TBL] [Abstract][Full Text] [Related]
7. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
8. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.
Kaul A; Shah A; Magill FH; Hawkins SA; Skaife P
Int J Surg; 2013; 11(4):329-31. PubMed ID: 23459187
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
[TBL] [Abstract][Full Text] [Related]
11. [A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].
Tarpay A; Szabadosné Németh M; Orosz E; Kásler M; Burai M; Pap A; Ottó S
Magy Onkol; 2011 Nov; 55(4):268-73. PubMed ID: 22128309
[TBL] [Abstract][Full Text] [Related]
12. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
13. Adenoma residua in colorectal cancer. A study of 34 colorectal cancers detected by an immunological occult blood test.
Häkkinen I; Järvi O; Nylamo E; Söderström KO
Ann Chir Gynaecol; 1993; 82(1):31-5. PubMed ID: 8323234
[TBL] [Abstract][Full Text] [Related]
14. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
[TBL] [Abstract][Full Text] [Related]
15. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
Manfredi S; Philip J; Campillo B; Piette C; Durand G; Riou F; Bretagne JF
Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
[TBL] [Abstract][Full Text] [Related]
16. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
17. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
18. Immunological fecal occult blood test vs. serum ferritin for detection of colorectal neoplasia in high risk asymptomatic population.
Sobrino-Cossío S; Fenocchi E; Hernández-Guerrero A; Alonso-Lárraga JO; De la Mora-Levy JG; Larracilla-Salazar I
Rev Gastroenterol Mex; 2011; 76(3):191-8. PubMed ID: 22041307
[TBL] [Abstract][Full Text] [Related]
19. Guaiac tests for detection of occult faecal blood loss in patients with endoscopically verified colonic polyps.
Gabrielsson N; Granqvist S; Nilsson B
Scand J Gastroenterol; 1985 Oct; 20(8):978-82. PubMed ID: 4081636
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
